Kindred Biosciences
(KIN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 13,960 | 15,986 | 39,164 | 31,980 | 68,598 |
| Marketable Securities | 39,493 | 55,723 | 48,279 | 47,601 | 27,390 |
| Receivables | 244 | 923 | 801 | 937 | 275 |
| Inventories | 824 | 4,218 | 4,223 | 4,358 | 4,525 |
| TOTAL | $58,414 | $79,345 | $93,995 | $86,745 | $102,712 |
| Non-Current Assets | |||||
| PPE Net | 30,292 | 29,777 | 29,574 | 28,576 | 28,136 |
| Investments And Advances | 1,118 | 1,837 | 201 | 0 | 0 |
| Other Non-Current Assets | 2,897 | 3,065 | 1,565 | 1,755 | 1,833 |
| TOTAL | $34,307 | $34,679 | $31,340 | $30,331 | $29,969 |
| Total Assets | $92,721 | $114,024 | $125,335 | $117,076 | $132,681 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,837 | 1,256 | 1,375 | 643 | 1,236 |
| Accrued Expenses | 6,740 | 8,324 | 8,007 | 6,261 | 9,347 |
| TOTAL | $10,195 | $10,224 | $10,112 | $7,638 | $11,291 |
| Non-Current Liabilities | |||||
| Long Term Debt | 19,350 | 19,265 | 19,189 | N/A | N/A |
| Other Non-Current Liabilities | 2,506 | 2,614 | 804 | 991 | 1,096 |
| TOTAL | $21,856 | $21,879 | $19,993 | $991 | $1,096 |
| Total Liabilities | $32,051 | $32,103 | $30,105 | $8,629 | $12,387 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 39,290 | 39,290 | 39,091 | 39,061 | 39,005 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -245,820 | -223,059 | -207,325 | -192,032 | -177,725 |
| Other shareholders' equity | 4 | 13 | 18 | 13 | -13 |
| TOTAL | $60,670 | $81,921 | $95,230 | $108,447 | $120,294 |
| Total Liabilities And Equity | $92,721 | $114,024 | $125,335 | $117,076 | $132,681 |